Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Forsyth

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogensJohn J P Kelly, Owen Stechishin, Andrew Chojnacki, et al.
The Lancet. Oncology|December 3, 2005
Health-related quality of life in patients with glioblastoma: a randomised controlled trialMartin J B Taphoorn, Roger Stupp, Corneel Coens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivorsEric C Burton, Kathleen R Lamborn, Peter Forsyth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Neuro-Oncology|January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Annals of Neurosciences|September 11, 2014
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cellsSusobhan Sarkar, Axinia Döring, Franz J Zemp, et al.
Nature Neuroscience|December 10, 2013
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cellsSusobhan Sarkar, Axinia Döring, Franz J Zemp, et al.
Neuro-Oncology Advances|January 22, 2026
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanismsKyle M Heemskerk, Samir Assaf, Xiaoguang Hao, et al.
Journal of Neuro-Oncology|November 11, 2022
Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology departmentJames K C Liu, Richard Kang, Arkady Bilenkin, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogensJohn J P Kelly, Owen Stechishin, Andrew Chojnacki, et al.
The Lancet. Oncology|December 3, 2005
Health-related quality of life in patients with glioblastoma: a randomised controlled trialMartin J B Taphoorn, Roger Stupp, Corneel Coens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivorsEric C Burton, Kathleen R Lamborn, Peter Forsyth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Neuro-Oncology|January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Annals of Neurosciences|September 11, 2014
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cellsSusobhan Sarkar, Axinia Döring, Franz J Zemp, et al.
Nature Neuroscience|December 10, 2013
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cellsSusobhan Sarkar, Axinia Döring, Franz J Zemp, et al.
Neuro-Oncology Advances|January 22, 2026
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanismsKyle M Heemskerk, Samir Assaf, Xiaoguang Hao, et al.
Journal of Neuro-Oncology|November 11, 2022
Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology departmentJames K C Liu, Richard Kang, Arkady Bilenkin, et al.
Pageof 8